Awm Investment Company Boosted By $387,728 Its Castlight Health (CSLT) Holding, Profile of 2 Analysts Covering Roka Bioscience (ROKA)

June 20, 2017 - By Vivian Currie

Awm Investment Company Inc increased Castlight Health Inc. (CSLT) stake by 24.23% reported in 2016Q4 SEC filing. Awm Investment Company Inc acquired 96,932 shares as Castlight Health Inc. (CSLT)’s stock 0.00%. The Awm Investment Company Inc holds 496,932 shares with $2.46M value, up from 400,000 last quarter. Castlight Health Inc. now has $548.91M valuation. It closed at $4.05 lastly. It is down 18.00% since June 20, 2016 and is downtrending. It has underperformed by 34.70% the S&P500.

Among 5 analysts covering Roka Bioscience (NASDAQ:ROKA), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Roka Bioscience had 9 analyst reports since August 14, 2015 according to SRatingsIntel. The stock of Roka Bioscience Inc (NASDAQ:ROKA) earned “Outperform” rating by Leerink Swann on Friday, August 14. Zacks downgraded Roka Bioscience Inc (NASDAQ:ROKA) on Tuesday, August 25 to “Hold” rating. Leerink Swann downgraded Roka Bioscience Inc (NASDAQ:ROKA) rating on Monday, March 7. Leerink Swann has “Market Perform” rating and $1 target. TH Capital initiated it with “Buy” rating and $10 target in Tuesday, December 13 report. The rating was initiated by Roth Capital on Tuesday, December 13 with “Buy”. The rating was upgraded by Zacks on Tuesday, September 8 to “Hold”. See Roka Bioscience Inc (NASDAQ:ROKA) latest ratings:

It closed at $2.5 lastly. It is down 50.49% since June 20, 2016 and is downtrending. It has underperformed by 67.19% the S&P500.

Roka Bioscience, Inc. is a molecular diagnostics company. The company has market cap of $11.59 million. The Firm is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. It currently has negative earnings. The Firm offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.

Investors sentiment decreased to 1.37 in Q4 2016. Its down 0.32, from 1.69 in 2016Q3. It worsened, as 11 investors sold CSLT shares while 24 reduced holdings. 18 funds opened positions while 30 raised stakes. 40.49 million shares or 1.13% more from 40.04 million shares in 2016Q3 were reported. Blackrock Invest Limited Company has 158,039 shares. 582,351 are owned by D E Shaw Communications Incorporated. Morgan Stanley owns 2.31 million shares for 0% of their portfolio. Great West Life Assurance Can invested 0% in Castlight Health Inc (NYSE:CSLT). Blackrock Fund Advsr has invested 0% of its portfolio in Castlight Health Inc (NYSE:CSLT). Maverick has 0.08% invested in Castlight Health Inc (NYSE:CSLT) for 1.19 million shares. Polar Capital Llp reported 317,260 shares or 0.03% of all its holdings. Needham Investment Mgmt Limited Liability Corp invested in 0.11% or 90,000 shares. Nationwide Fund reported 24,357 shares stake. Royal Financial Bank Of Canada reported 5,214 shares. Natl Bank Of Montreal Can reported 29,744 shares. Legal General Gp Public Ltd has invested 0% in Castlight Health Inc (NYSE:CSLT). Vanguard Grp reported 0% in Castlight Health Inc (NYSE:CSLT). Thompson Davis And invested in 60,615 shares. Tiaa Cref Inv Mngmt Ltd, New York-based fund reported 105,822 shares.

Since February 15, 2017, it had 0 insider purchases, and 11 insider sales for $449,834 activity. 16,624 shares valued at $61,240 were sold by DOYLE JOHN C on Wednesday, February 15. 34,961 shares were sold by Colella Giovanni M., worth $129,315. 2,765 shares were sold by Nolan Mangini Siobhan, worth $10,420. 14,759 shares were sold by McCracken John, worth $53,401 on Thursday, February 16. 20,916 shares valued at $76,280 were sold by Rende Jonathan on Wednesday, February 15. 7,858 shares were sold by Jain Priya, worth $28,671.

Among 12 analysts covering Castlight Health (NYSE:CSLT), 5 have Buy rating, 1 Sell and 6 Hold. Therefore 42% are positive. Castlight Health had 19 analyst reports since October 9, 2015 according to SRatingsIntel. The stock of Castlight Health Inc (NYSE:CSLT) has “Underperform” rating given on Monday, May 15 by Morgan Stanley. Topeka Capital Markets initiated Castlight Health Inc (NYSE:CSLT) rating on Wednesday, December 16. Topeka Capital Markets has “Buy” rating and $6.5 target. Stifel Nicolaus maintained Castlight Health Inc (NYSE:CSLT) on Thursday, February 18 with “Buy” rating. The rating was maintained by Topeka Capital Markets with “Buy” on Thursday, February 18. The firm has “Mkt Perform” rating given on Thursday, November 5 by Leerink Swann. The company was downgraded on Thursday, January 5 by Raymond James. The firm has “Mkt Perform” rating given on Wednesday, November 18 by FBR Capital. On Friday, October 9 the stock rating was upgraded by First Analysis to “Overweight”. Dougherty & Company initiated the shares of CSLT in report on Wednesday, May 10 with “Buy” rating. The stock of Castlight Health Inc (NYSE:CSLT) earned “Mkt Perform” rating by FBR Capital on Wednesday, May 11.

Awm Investment Company Inc decreased Mcbc Holdings Inc. stake by 32,376 shares to 452,065 valued at $6.59M in 2016Q4. It also reduced Lendingtree Inc. stake by 20,000 shares and now owns 48,000 shares. Vocera Communications Inc. (NYSE:VCRA) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: